Infinimmune, a biotechnology company pioneering new methods for antibody drug discovery and development, announced today the appointment of Tim Sullivan, Ph.D., as Chief Business Officer. In this newly created role, Dr. Sullivan, who has decades of experience as a senior executive in the biotechnology and pharmaceutical industry, will be responsible for corporate and business development initiatives, as well as corporate and product strategic planning.

https://www.businesswire.com/news/home/20240903196986/en/Infinimmune-Appoints-Dr.-Tim-Sullivan-as-Chief-Business-Officer